Global WholeHealth Partners Corporation (GWHP)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.0006 - Volume
1,051,610 - Avg. Volume
16,692 - Market Cap (intraday)
13,129 - Beta (5Y Monthly) 21.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic (IVD) test kits in the United States. The company offers approximately 125 diagnostic tests kits for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, yellow fever, and other epidemic and vector-borne diseases. The company was incorporated in 2013 and is based in Newport Beach, California.
gwhpcorp.comRelated News
Performance Overview: GWHP
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GWHP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GWHP
Valuation Measures
Market Cap
13.13k
Enterprise Value
705.26k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.27
Price/Book (mrq)
--
Enterprise Value/Revenue
95.63
Enterprise Value/EBITDA
-0.17
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-1,194.28%
Return on Equity (ttm)
--
Revenue (ttm)
7.38k
Net Income Avi to Common (ttm)
-5.15M
Diluted EPS (ttm)
-0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
44.08k
Company Insights: GWHP
GWHP does not have Company Insights